Drug to fight ALS gets a boost from FDA

Image: Stephen Hawking

British physicist Stephen Hawking, shown here during a 2016 interview with Larry King, is almost completely paralyzed due to ALS but still leads an active professional life (Credit: Ora.TV)

Revalesio, a biomedical company headquartered in Tacoma, Wash., says it’s been cleared to benefit from federal incentives for the development of a drug that could help treat a neurodegenerative disease known as amyotrophic lateral sclerosis, or ALS.

ALS is known as Lou Gehrig’s disease, but today’s most famous patient is British physicist Stephen Hawking, who was diagnosed with the malady more than 50 years ago.

The disease affects 12,000 to 15,000 patients in the U.S., and an estimated 6,000 Americans are diagnosed with ALS every year.

Get the full story on GeekWire.

About Alan Boyle

Award-winning science writer, creator of Cosmic Log, author of "The Case for Pluto: How a Little Planet Made a Big Difference," president of the Council for the Advancement of Science Writing. Check out "About Alan Boyle" for more fun facts.
This entry was posted in GeekWire and tagged , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s